186 related articles for article (PubMed ID: 11708188)
1. Zidovudine (Retrovir).
Res Initiat Treat Action; 2000 Mar; 6(1):6-7. PubMed ID: 11708188
[No Abstract] [Full Text] [Related]
2. Didanosine (Videx).
Res Initiat Treat Action; 2000 Mar; 6(1):8-9. PubMed ID: 11708189
[No Abstract] [Full Text] [Related]
3. Delavirdine (Rescriptor).
Res Initiat Treat Action; 2000 Mar; 6(1):20-1. PubMed ID: 11708180
[No Abstract] [Full Text] [Related]
4. Nevirapine (Viramune).
Res Initiat Treat Action; 2000 Mar; 6(1):18-9. PubMed ID: 11708179
[No Abstract] [Full Text] [Related]
5. Lamivudine (Epivir).
Res Initiat Treat Action; 2000 Mar; 6(1):14-5. PubMed ID: 11708177
[No Abstract] [Full Text] [Related]
6. Stavudine (Zerit).
Res Initiat Treat Action; 2000 Mar; 6(1):12-3. PubMed ID: 11708176
[No Abstract] [Full Text] [Related]
7. Zalcitabine (Hivid).
Res Initiat Treat Action; 2000 Mar; 6(1):10-1. PubMed ID: 11708175
[No Abstract] [Full Text] [Related]
8. Viral resistance: a major challenge in managing HIV disease.
Boucher CA; Reedijk M
J Biol Regul Homeost Agents; 1995; 9(3):91-4. PubMed ID: 8782014
[No Abstract] [Full Text] [Related]
9. Abacavir (Ziagen).
Res Initiat Treat Action; 2000 Mar; 6(1):16-7. PubMed ID: 11708178
[No Abstract] [Full Text] [Related]
10. Efavirenz (Sustiva).
Res Initiat Treat Action; 2000 Mar; 6(1):22-3. PubMed ID: 11708181
[No Abstract] [Full Text] [Related]
11. [New trends in HIV].
Volkert R
Dtsch Med Wochenschr; 1998 Sep; 123(38):A7. PubMed ID: 9787287
[No Abstract] [Full Text] [Related]
12. Zidovudine.
Nurs Times; 2005 Nov 29-Dec 5; 101(48):33. PubMed ID: 16350517
[No Abstract] [Full Text] [Related]
13. FDA notifications. FDA approved pediatric efficacy supplement for Retrovir syrup.
AIDS Alert; 2008 Nov; 23(11):128. PubMed ID: 19043870
[No Abstract] [Full Text] [Related]
14. A decade in HIV treatment: what is the state of the art and how did we arrive.
Tamari M
Clin Excell Nurse Pract; 2001; 5(1):4-12. PubMed ID: 11154387
[TBL] [Abstract][Full Text] [Related]
15. Resistance of HIV to antiretroviral agents. Basic concepts.
Dianzani F; Antonelli G; Turriziani O
J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):19-22. PubMed ID: 9689574
[No Abstract] [Full Text] [Related]
16. Retrovir efficacy supplement approved.
AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043841
[No Abstract] [Full Text] [Related]
17. Buffalo hump: what the experts suggest.
Piliero PJ; McComsey GA
AIDS Clin Care; 2004 Mar; 16(3):22-3. PubMed ID: 15119294
[No Abstract] [Full Text] [Related]
18. [Resistance to nucleoside reverse transcriptase inhibitors].
Leal M; Santamaría JM
Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):26-9. PubMed ID: 11428055
[No Abstract] [Full Text] [Related]
19. Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC.
Feinberg J
AIDS Clin Care; 2005 Jan; 17(1):7. PubMed ID: 15717373
[No Abstract] [Full Text] [Related]
20. [Resistance to antiretroviral drugs: a clinical, public health and health policy debate].
Guerra Romero L; Parras Vázquez F
Med Clin (Barc); 2000 Oct; 115(11):428-30. PubMed ID: 11093847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
